Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Schiffer

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Advances in Experimental Medicine and Biology|August 27, 2020
Chondroitin Sulphate Proteoglycans in the Tumour MicroenvironmentMarta Mellai, Cristina Casalone, Cristiano Corona, et al.
Cancer Genomics & Proteomics|August 7, 2009
MGMT promoter hypermethylation in a series of 104 glioblastomasMarta Mellai, Valentina Caldera, Laura Annovazzi, et al.
International Journal of Oncology|April 21, 2015
The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatmentLaura Annovazzi, Valentina Caldera, Marta Mellai, et al.
The Journal of Pathology. Clinical Research|May 22, 2019
SEL1L plays a major role in human malignant gliomasMarta Mellai, Laura Annovazzi, Renzo Boldorini, et al.
Anticancer Research|August 17, 2005
Characterization of the 20S proteasome in human glioblastomasMarco Piccinini, Maria Teresa Rinaudo, Annalisa Anselmino, et al.
Molecular Cancer Therapeutics|September 27, 2018
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in GlioblastomaIris C Salaroglio, Prashant Mujumdar, Laura Annovazzi, et al.
Histopathology|February 5, 2016
Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approachRebecca Senetta, Marta Mellai, Claudia Manini, et al.
International Journal of Molecular Sciences|September 15, 2018
The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human GliomasDavide Schiffer, Marta Mellai, Renzo Boldorini, et al.
Oncotarget|May 8, 2015
SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapyMarta Mellai, Monica Cattaneo, Alessandra Maria Storaci, et al.
Oncotarget|September 18, 2018
Correction: Marta Mellai, Monica Cattaneo, Alessandra Maria Storaci, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Advances in Experimental Medicine and Biology|August 27, 2020
Chondroitin Sulphate Proteoglycans in the Tumour MicroenvironmentMarta Mellai, Cristina Casalone, Cristiano Corona, et al.
Cancer Genomics & Proteomics|August 7, 2009
MGMT promoter hypermethylation in a series of 104 glioblastomasMarta Mellai, Valentina Caldera, Laura Annovazzi, et al.
International Journal of Oncology|April 21, 2015
The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatmentLaura Annovazzi, Valentina Caldera, Marta Mellai, et al.
The Journal of Pathology. Clinical Research|May 22, 2019
SEL1L plays a major role in human malignant gliomasMarta Mellai, Laura Annovazzi, Renzo Boldorini, et al.
Anticancer Research|August 17, 2005
Characterization of the 20S proteasome in human glioblastomasMarco Piccinini, Maria Teresa Rinaudo, Annalisa Anselmino, et al.
Molecular Cancer Therapeutics|September 27, 2018
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in GlioblastomaIris C Salaroglio, Prashant Mujumdar, Laura Annovazzi, et al.
Histopathology|February 5, 2016
Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approachRebecca Senetta, Marta Mellai, Claudia Manini, et al.
International Journal of Molecular Sciences|September 15, 2018
The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human GliomasDavide Schiffer, Marta Mellai, Renzo Boldorini, et al.
Oncotarget|May 8, 2015
SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapyMarta Mellai, Monica Cattaneo, Alessandra Maria Storaci, et al.
Oncotarget|September 18, 2018
Correction: Marta Mellai, Monica Cattaneo, Alessandra Maria Storaci, et al.
Pageof 6